| Author(s)/Faculty: Jacob L. Hutchins, MD | |||
| Type: Videos | |||
| Release Date: 12/1/2014 | Expiration Date: 11/30/2015 | ||
| Credit Type: CME/Participation | Number of Credit(s): .25 | ||
CME Information
This activity is part 1 of a 3 part series.
Support Statement: This activity is supported by an educational grant from Pacira Pharmaceuticals, Inc.
Target Audience: The intended audience for this activity is plastic surgeons and other healthcare professionals involved in the management of breast surgery patients.
Learning Objectives: Upon successful completion of this educational activity, participants should be better able to assess the benefits and risks of opioids and local analgesics to better select therapy that will meet the needs of individual patients and improve post-surgical outcomes.
Faculty
Jacob L. Hutchins, MD
Director of Perioperative and Interventional Pain Service
Department of Anesthesiology
University of Minnesota
Minneapolis, MN
This enduring material is approved for 1 year from the date of original release, December 1, 2014 to November 30, 2015.
External Reviewer
Seth Thaller, MD
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
Faculty member reports the following relationship(s):
Jacob L. Hutchins, MD
Consulting Fee: Pacira Pharmaceuticals, Inc
Speakers’ Bureau: Pacira Pharmaceuticals, Inc; I-Flow
Contracted Research: Pacira Pharmaceuticals, Inc
External Reviewer reports the following relationship(s):
Seth Thaller, MD, DMD
No relevant financial relationships to disclose
Overview
Pain control after reduction mammaplasty and breast reconstruction with tissue expanders often requires narcotic analgesia, thereby making opioids the cornerstone of pain management in the postoperative setting. However, opioids are limited by their abuse potential and side effect profile. As a result, local anesthetic agents and multimodal pain regimens are increasingly used for postsurgical pain control. In this activity, leading clinicians will discuss postoperative pain management goals and how they can be safely achieved using multimodal analgesia.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.